Delivery Order SPE2DB20D7059-SPE2DB25FQEZ4
Award Date
4/29/25
Potential Completion Date
4/30/25
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,034.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,560,799,928 tablets of the antibiotic Linezolid 600 mg. The contract is a delivery order that runs through May 3, 2023, with a firm fixed price. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Linezolid 600 mg tablets to support military healthcare programs. The $1,741.41 delivery order was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, as a child contract under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between the DLA and the parent company, Cencora, Inc. (doing business as Amerisourcebergen). This IDC serves as the primary...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567060100 LINEZOLID 600 MG TABLET 20S, a prescription medication, with an ultimate completion date of January 28, 2025 and a ceiling value of $4,726.51. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open...
This federal contract award, with ID SPE2DX15D1053|SPE2DX23F6VPX, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp as the prime contractor. The contract is for the delivery of 150 ml bottles of the pharmaceutical drug Linezolid 100 mg/5 ml suspension, with a ceiling value of $8,698.66 and a period of performance through October 2, 2023. The contract is a firm-fixed-price Delivery Order, without a set-aside designation, indicating open...
This federal contract award, valued at $642,324.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of June 7, 2024. The contract provides for the delivery of a wide range of pharmaceutical and medical products, including medications across various therapeutic domains such as diabetes,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,086.08 firm-fixed-price delivery order is for LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has an ultimate completion date of June 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $753,227.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the provision of a range of pharmaceutical products and medical supplies, including medications across various therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract is a firm fixed-price, non-set-aside award, indicating open competition....
This federal contract award, valued at $299,900.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award, valued at $2,782.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract with a firm fixed price, with an ultimate completion date of April 21, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $844,462.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is April 25, 2024. The contract provides for the delivery of a wide range of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes...